• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿根廷的耐青霉素肺炎链球菌:国际传播的血清型14克隆株频繁出现。

Penicillin-resistant Streptococcus pneumoniae in Argentina: frequent occurrence of an internationally spread serotype 14 clone.

作者信息

Rossi A, Corso A, Pace J, Regueira M, Tomasz A

机构信息

Servicio Antimicrobianos, Instituto Nacional de Enfermedades Infecciosas, A.N.L.I.S, Dr. C. Malbrán, Buenos Aires, Argentina.

出版信息

Microb Drug Resist. 1998 Fall;4(3):225-31. doi: 10.1089/mdr.1998.4.225.

DOI:10.1089/mdr.1998.4.225
PMID:9818974
Abstract

Six Latin-American countries participated in an epidemiological surveillance study conducted by the Pan American Health Organization in order to determine the relative prevalence of capsular types and antimicrobial resistance patterns of Streptococcus pneumoniae (SPN) causing invasive infections in children <5 years of age. In Argentina, the incidence of penicillin resistance (PR) was 24.4%, and it was significantly associated with serotype 14 (p < 0.001). The chromosomal DNA of 56 of those SPN isolates, 39 PR and 17 susceptible, was digested with SmaI and resolved by PFGE. Eighty-two percent (32/39) of the PR isolates shared characteristics with the widely spread International Spanish/French clone (clone B). All members of clone B except one expressed serotype 14, with the exception of one isolate that expressed serotype 19F and probably resulted from an in vivo capsular transformation event. Only a single isolate shared features with the 23F International Spanish/USA clone (clone A). The 17 penicillin-susceptible (PS) SPN isolates presented an enormous degree of variation in the chromosomal background, expressing 12 serotypes and 13 PFGE patterns. The data suggest that over 80% of the SPN-PR isolates in Argentina were imported, and this confirms the importance of the geographic spread of SPN clones in South America.

摘要

六个拉丁美洲国家参与了泛美卫生组织开展的一项流行病学监测研究,以确定引起5岁以下儿童侵袭性感染的肺炎链球菌(SPN)的荚膜类型相对流行率和抗菌药物耐药模式。在阿根廷,青霉素耐药(PR)发生率为24.4%,且与14型显著相关(p<0.001)。对其中56株SPN分离株的染色体DNA(39株PR分离株和17株敏感分离株)用SmaI进行酶切,并通过脉冲场凝胶电泳(PFGE)进行分析。82%(32/39)的PR分离株与广泛传播的国际西班牙/法国克隆株(克隆B)具有共同特征。除一株外,克隆B的所有成员均表达14型,有一株表达19F型,可能是体内荚膜转化事件导致的。只有一株分离株与23F国际西班牙/美国克隆株(克隆A)具有共同特征。17株青霉素敏感(PS)SPN分离株的染色体背景存在很大差异,表达12种血清型和13种PFGE模式。数据表明,阿根廷超过80%的SPN-PR分离株是输入性的,这证实了SPN克隆在南美洲地理传播的重要性。

相似文献

1
Penicillin-resistant Streptococcus pneumoniae in Argentina: frequent occurrence of an internationally spread serotype 14 clone.阿根廷的耐青霉素肺炎链球菌:国际传播的血清型14克隆株频繁出现。
Microb Drug Resist. 1998 Fall;4(3):225-31. doi: 10.1089/mdr.1998.4.225.
2
Molecular characterization of penicillin-resistant Streptococcus pneumoniae isolates causing respiratory disease in the United States.在美国引起呼吸道疾病的耐青霉素肺炎链球菌分离株的分子特征分析
Microb Drug Resist. 1998 Winter;4(4):325-37. doi: 10.1089/mdr.1998.4.325.
3
Predominance of the multiresistant 23F international clone of Streptococcus pneumoniae among isolates from Mexico.墨西哥分离出的肺炎链球菌中多重耐药23F国际克隆株占主导地位。
Microb Drug Resist. 1998 Fall;4(3):241-6. doi: 10.1089/mdr.1998.4.241.
4
The apparent importation of penicillin-resistant capsular type 14 Spanish/French clone of Streptococcus pneumoniae into Uruguay in the early 1990s.20世纪90年代初,肺炎链球菌对青霉素耐药的14型西班牙/法国克隆菌株明显传入乌拉圭。
Microb Drug Resist. 1998 Fall;4(3):219-24. doi: 10.1089/mdr.1998.4.219.
5
Penicillin-resistant Streptococcus pneumoniae in Colombia: presence of international epidemic clones. Colombian pneumococcal study group.哥伦比亚耐青霉素肺炎链球菌:国际流行克隆株的存在。哥伦比亚肺炎链球菌研究小组
Microb Drug Resist. 1998 Fall;4(3):233-9. doi: 10.1089/mdr.1998.4.233.
6
Molecular epidemiology of penicillin-resistant Streptococcus pneumoniae isolates recovered in Italy from 1993 to 1996.1993年至1996年在意大利分离出的耐青霉素肺炎链球菌的分子流行病学研究。
J Clin Microbiol. 1998 Oct;36(10):2944-9. doi: 10.1128/JCM.36.10.2944-2949.1998.
7
Spread of the serotype 23F multidrug-resistant Streptococcus pneumoniae clone to South Korea.23F血清型多重耐药肺炎链球菌克隆株向韩国的传播。
Microb Drug Resist. 1997 Spring;3(1):105-9. doi: 10.1089/mdr.1997.3.105.
8
Genetic relatedness of resistant and multiresistant Streptococcus pneumoniae strains, recovered in the Athens area, to international clones.在雅典地区分离出的耐药和多重耐药肺炎链球菌菌株与国际克隆株的遗传相关性。
Microb Drug Resist. 2002 Fall;8(3):219-26. doi: 10.1089/107662902760326940.
9
Novel penicillin-, cephalosporin-, and macrolide-resistant clones of Streptococcus pneumoniae serotypes 23F and 19F in Taiwan which differ from international epidemic clones.台湾地区肺炎链球菌23F和19F血清型的新型耐青霉素、头孢菌素和大环内酯类克隆株,与国际流行克隆株不同。
J Clin Microbiol. 2001 Mar;39(3):1144-7. doi: 10.1128/JCM.39.3.1144-1147.2001.
10
Presence of international multiresistant clones of Streptococcus pneumoniae in Colombia.哥伦比亚肺炎链球菌国际多重耐药克隆的存在情况。
Microb Drug Resist. 2001 Summer;7(2):153-64. doi: 10.1089/10766290152045020.

引用本文的文献

1
Serotype competence and penicillin resistance in Streptococcus pneumoniae.肺炎链球菌的血清型能力与青霉素耐药性
Emerg Infect Dis. 2006 Nov;12(11):1709-14. doi: 10.3201/eid1211.060414.
2
Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network.由肺炎球菌分子流行病学网络定义的肺炎链球菌主要耐药克隆的命名法。
J Clin Microbiol. 2001 Jul;39(7):2565-71. doi: 10.1128/JCM.39.7.2565-2571.2001.
3
Molecular evolution in a multidrug-resistant lineage of Streptococcus pneumoniae: emergence of strains belonging to the serotype 6B Icelandic clone that lost antibiotic resistance traits.
肺炎链球菌多重耐药谱系中的分子进化:属于6B血清型冰岛克隆株且丧失抗生素耐药性状的菌株的出现。
J Clin Microbiol. 2000 Apr;38(4):1375-81. doi: 10.1128/JCM.38.4.1375-1381.2000.
4
Dissemination of a chloramphenicol- and tetracycline-resistant but penicillin-susceptible invasive clone of serotype 5 Streptococcus pneumoniae in Colombia.在哥伦比亚传播的对氯霉素和四环素耐药但对青霉素敏感的5型肺炎链球菌侵袭性克隆株。
J Clin Microbiol. 1999 Jul;37(7):2337-42. doi: 10.1128/JCM.37.7.2337-2342.1999.